See also this year's filing and all EDGAR filings for this company.
PDF Report 0001253689_2021_Crescent_Biopharma_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001253689, Crescent Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 138,273,345 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 620,673 |
| 3 | remainder_Assets | 3,938,151 |
| 4 | LiabilitiesCurrent | 12,428,369 |
| 5 | LiabilitiesNoncurrent | 1,920,015 |
| 6 | remainder_Liabilities | 264,329 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,342,433 |
| 9 | ResearchAndDevelopmentExpense | 44,092,799 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 9,788,791 |
| 12 | remainder_NetIncome | -731,196 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 142,832,169 |
| 1 | Liabilities | 14,612,713 |
| 2 | Expenses | 62,435,232 |
| 3 | Revenues | 9,788,791 |
| 4 | StockholdersEquity | 128,219,456 |
| 5 | NetIncome | -53,377,637 |
| 6 | ComprehensiveNetIncome | -53,377,637 |
| 7 | BaseVar | 115,200,050 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.87 |
| 9 | EconomicCapitalRatio | 3.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
